September 11, 2018 | Dory Benford
Johnny Lopez's research into the latest prostate cancer treatments, clinical trials, experimental therapies — anything to avoid chemotherapy, and a recommendation from a friend also battling prostate cancer, led him to Tanya Dorff, M.D., and City of Hope.
New Clues Could Point to Better Treatments for Chronic Graft-Versus-Host Disease (GVHD)
November 9, 2017 | By Katie Neith
City of Hope’s Defu Zeng, professor of diabetes immunology and hematopoietic cell transplantation and colleagues recently uncovered important information about the chronic GVHD.
Meet our doctors: Jonathan Cotliar on graft-versus-host disease
February 20, 2015 | Kim Proescholdt
Each year, thousands of patients with hematologic malignancies undergo allogeneic stem cell transplantation (that is, they receive a donor's stem cells), offering them a chance at cure. Graft-versus-host disease is a potentially deadly complication of this therapy and occurs in approximately 25 to 60 percent of patients.